Life Sciences Industry

Pictured:Eli Lilly's headquarters in Indianapolis

Lilly Touts26%Q1 Revenue Growth on Strong Mounjaro Sales,Raises Full-年Guidance by$2B

Thanks to strong sales of its blockbuster drugs Mounjaro and Zepbound,Eli Lilly on Tuesday reported nearly$8.77 billion in revenue in the first quarter of 2024,while raising its full-year revenue guidance by$2billion。
Pictued:Pfizer sign at it world headquarters in

Pfizer,Genmab’s ADC Tivdak Scores Full FDA Approval in Recurrent or Metastatic Cervical Cancer

Based on strong overall and progression-free survival data in its Phase III confirmatory study,Pfizer and Genmab’s antibody-drug conjugate Tivdak on Monday secured the FDA’s full approval for recurent or metatic cervical cancer that had progressed on or after chemotherapy。